TABLE 4.
Analyte | Method | Results | References |
---|---|---|---|
Indigo | 1H-NMR | 1.4–2.7% | Plitzko et al. (2009) |
Indigo | HPLC | 1.1–1.4% | Plitzko et al. (2009) |
Indirubin | HPLC | 0.16–0.37% | Plitzko et al. (2009) |
Indigo | HPLC | 1.18–3.47% | Pan et al. (2018) |
Indirubin | HPLC | 0.09–0.26% | Pan et al. (2018) |
Indigo | FTIR spectroscopy | 1.46–2.82% | Pan et al. (2018) |
Indirubin | FTIR spectroscopy | 0.12–0.23% | Pan et al. (2018) |
CaCO3 | ICP-OES | 59.125–96.175% | Pan et al. (2018) |
CaCO3 | FTIR spectroscopy | 60.925–87.125% | Pan et al. (2018) |
Indigo | HPLC | 30.07% | Sun Z. et al. (2020) |
Indirubin | HPLC | 0.145% | Sun Z. et al. (2020) |
Indigo | UPLC | 13.87% | Liang et al. (2019) |
Indirubin | UPLC | 0.15% | Liang et al. (2019) |
Indole | UPLC-APCI-TOFMS | 0.0002574% | Naganuma et al. (2018) |
Indole-3-aldehyde | UPLC-APCI-TOFMS | 0.0000203% | Naganuma et al. (2018) |
Tryptanthrin | UPLC-APCI-TOFMS | 0.000124% | Naganuma et al. (2018) |
Indigo | UPLC-APCI-TOFMS | 0.2507% | Naganuma et al. (2018) |
Indirubin | UPLC-APCI-TOFMS | 0.08347% | Naganuma et al. (2018) |
Betulin | UPLC-APCI-TOFMS | 0.0007956% | Naganuma et al. (2018) |
β-Sitosterol | UPLC-APCI-TOFMS | 0.003974% | Naganuma et al. (2018) |
Daucosterol | UPLC-APCI-TOFMS | 0.0009216% | Naganuma et al. (2018) |
Indican | UPLC-ESI-TOFMS | 0.00001328% | Naganuma et al. (2018) |
Anthranilic acid | UPLC-ESI -TOFMS | 0.001356% | Naganuma et al. (2018) |
Indigo | Q-TOFMS | 13.81% | Wu et al. (2016) |
Indirubin | Q-TOFMS | 3.7% | Wu et al. (2016) |
Tryptanthrin | Q-TOFMS | 0.72% | Wu et al. (2016) |
Isorhamnetin | Q-TOFMS | 0.04% | Wu et al. (2016) |
CaCO3 | Titration | 68.51%–71.50% | Wang (2004) |
Silica | Titration | 7.78–11.09% | Wang (2004) |